We can move toward free market reforms in drug pricing. We must overturn the current perverse incentives that favor the ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The EO revives effort to link U.S. drug prices to those in peer countries, calling for voluntary industry action. Aggressive ...

China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most ...

While President Donald Trump may wish he lives and works in the Hogwarts School of Witchcraft and Wizardry and has Harry ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

The order calls on the health department, led by Robert F. Kennedy Jr., to broker new price tags for drugs over the next ...

Pfizer (PFE), and Eli Lilly (LLY) traded in the green Monday morning despite declining in pre-market hours after President ...

Pfizer reaffirmed $10–$15 billion for business development, with focus on immunology and cardiometabolic expansion. CEO Bourla says national security concerns are central to U.S. drug ...

there is potential to disrupt drug development costs and drug prices, with any tariffs increasing the import costs of many raw materials and active pharmaceutical ingredients, according to GlobalData, ...